Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

Clinical trial NCT07610837 · RECRUITING

Trial details

NCT number: NCT07610837
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Fibrosis Hepatic Cirrhosis

Start date: 2026-05-07
Primary completion: 2027-07-07
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.